Company Deep Dive

Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.

Request Deep Dive(50 Feathers)

GLAS

HOLD

Glass House Brands Inc. · Healthcare · United States · $899M · Avg Vol: $4M/d

35
StockRank
Get insider-trade alerts
Q
36
V
25
M
66
P/E (TTM)
—
ROE
-20.4%
D/E
0.4x
Dividend %
—
Dir. Trades · 180d
None →
Buybacks · 180d
None →

COMPANY DESCRIPTION

Glass House Brands is a California-based cannabis company involved in the cultivation, processing, and retail sale of cannabis products. It utilizes a vertically integrated business model, which allows it to maintain cost leadership and quality control in the highly competitive California market.

Loading 1Y...
PRICE (1Y)-23.6%
10.0210.9111.8012.6913.58Jun 12Jul 7Jul 27
SMA 50SMA 200
Close
$10.12
RSI (14)
27.8
52W High
$13.93
From 52W High
0.7%

SCORE BREAKDOWN

Quality
36
ROIC
-5.9%39.4
ROE
-20.4%31.2
GP/Assets
21.0%49.9
Op. Margin
-35.4%23.6
FCF/Assets
-8.4%30.9
Piotroski
239.0
Int. Cover
-2.9x31.2
D/E Ratio
0.42x34.1
Current Ratio
1.85x34.3
Value
25
P/E (TTM)
—N/A
EV/EBITDA
-100.8x25.0
P/FCF
—N/A
P/B
11.0x10.2
P/S
5.1x41.8
Div Yield
—N/A
Momentum
66
52W High %
73%58.2
RS 6M
-1%71.8
SMA 50/200
1.28x93.2
EPS Rev 4W
—N/A
EPS Rev 12W
—N/A
EPS Improve
+144%82.9
Q Growth
—N/A

FUNDAMENTALS

Market Cap
$899M
P/E (Forward)
37.8x
Gross Margin
37.7%

SECTOR PEERS

Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of GLAS are excluded.

TickerCompanyMkt CapStockRankSignal
GLASGlass House Brands Inc.(you)$899M35HOLD
ESPREsperion Therapeutics, Inc.$817M33SELL
BIOABioAge Labs, Inc.$968M31SELL
HROWHarrow, Inc.$1.5B35SELL
VREO.CNVireo Growth Inc.$500M36HOLD
EOLSEvolus, Inc.$394M39HOLD
AKBAAkebia Therapeutics, Inc.$327M33SELL
AMLXAmylyx Pharmaceuticals, Inc.$2.0B28SELL
ORGOOrganogenesis Holdings Inc.$308M39HOLD
TKNOAlpha Teknova, Inc.$266M36HOLD

Peer medians: ROE -25.6% · P/E 27.6x · Gross margin 50.6%

Glass House Brands Inc. (GLAS) — Stock Score Summary

Glass House Brands Inc. (GLAS) has a MoatMap StockRank of 35/100 based on Quality (36/100), Value (25/100), and Momentum (66/100) factor scores. The current signal is HOLD.

Glass House Brands is a California-based cannabis company involved in the cultivation, processing, and retail sale of cannabis products. It utilizes a vertically integrated business model, which allows it to maintain cost leadership and quality control in the highly competitive California market.

Key Financial Metrics

Price$10.12
Market Cap$899M
P/E (Forward)37.81
Price/Book11.04
Return on Equity-20.4%
Return on Invested Capital-5.9%
Debt/Equity0.42x
Gross Margin37.7%
Operating Margin-35.4%
Revenue Growth-9.6%
Free Cash Flow$-27M

Glass House Brands Inc. operates in the Drug Manufacturers - Specialty & Generic industry, part of the Healthcare sector (United States).

Frequently Asked Questions

What is Glass House Brands Inc.’s (GLAS) StockRank?
MoatMap’s StockRank for Glass House Brands Inc. (GLAS) is 35/100, with a Hold signal. It is a composite of Quality (36), Value (25), and Momentum (66) factor ranks across MoatMap’s 20,000+ stock universe.
Does Glass House Brands Inc. have an economic moat?
Glass House Brands Inc. (GLAS) has a Quality factor score of 36/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Glass House Brands Inc. a buy, hold, or sell?
MoatMap’s current signal for Glass House Brands Inc. (GLAS) is Hold, based on a StockRank of 35/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is Glass House Brands Inc. in?
Glass House Brands Inc. (GLAS) operates in the Healthcare sector, specifically the Drug Manufacturers - Specialty & Generic industry (United States).
Browse all ranked stocksGLAS deep dive reportAI ChampionsHow we score stocksSense-check another stock